MX2019014546A - A peptide with anti-cancer activity and with selectivity to breast cancer cells. - Google Patents

A peptide with anti-cancer activity and with selectivity to breast cancer cells.

Info

Publication number
MX2019014546A
MX2019014546A MX2019014546A MX2019014546A MX2019014546A MX 2019014546 A MX2019014546 A MX 2019014546A MX 2019014546 A MX2019014546 A MX 2019014546A MX 2019014546 A MX2019014546 A MX 2019014546A MX 2019014546 A MX2019014546 A MX 2019014546A
Authority
MX
Mexico
Prior art keywords
peptide
breast cancer
selectivity
cancer cells
activity
Prior art date
Application number
MX2019014546A
Other languages
Spanish (es)
Inventor
Correa Catalina Soriano
Salcedo Carolina Barrientos
CRUZ María Isabel SOTO
Cortés Mercedes Bermúdez
Herrera Martha Legorreta
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2019014546A priority Critical patent/MX2019014546A/en
Priority to PCT/MX2020/050045 priority patent/WO2021112662A1/en
Publication of MX2019014546A publication Critical patent/MX2019014546A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to the design of a novel peptide of the pharmaceutical interest and with application in antitumor therapy in breast cancer cells. Said peptide has a hexa-peptide structure corresponding to a sequence of six amino acids repeated five times (FSKWLL). Also, it aims to form part of the therapeutic schemes used in breast cancer, particularly in those tumors that do not show expression of the extracellular domain of the EGFR protein, which is the target of the drug Herceptin. Further, it may be useful after resection and before starting chemotherapy.
MX2019014546A 2019-12-04 2019-12-04 A peptide with anti-cancer activity and with selectivity to breast cancer cells. MX2019014546A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2019014546A MX2019014546A (en) 2019-12-04 2019-12-04 A peptide with anti-cancer activity and with selectivity to breast cancer cells.
PCT/MX2020/050045 WO2021112662A1 (en) 2019-12-04 2020-11-24 Peptide with anticancer activity against breast cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2019014546A MX2019014546A (en) 2019-12-04 2019-12-04 A peptide with anti-cancer activity and with selectivity to breast cancer cells.

Publications (1)

Publication Number Publication Date
MX2019014546A true MX2019014546A (en) 2023-01-10

Family

ID=76222632

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014546A MX2019014546A (en) 2019-12-04 2019-12-04 A peptide with anti-cancer activity and with selectivity to breast cancer cells.

Country Status (2)

Country Link
MX (1) MX2019014546A (en)
WO (1) WO2021112662A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020046793A1 (en) 2018-08-27 2020-03-05 Regeneron Pharmaceuticals, Inc. Use of raman spectroscopy in downstream purification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017013613A (en) * 2015-04-23 2018-09-12 Nantomics Llc CANCER NEOEPITODES.

Also Published As

Publication number Publication date
WO2021112662A1 (en) 2021-06-10

Similar Documents

Publication Publication Date Title
EP4378962A3 (en) Anti-cancer fusion polypeptide
EA201692103A1 (en) NEW METHOD OF IMMUNOTHERAPY OF SEVERAL TYPES OF TUMOR DISEASES OF THE BLOOD, SUCH AS AN ACUTE MYELOID LEUKEMIA (AML)
EA201791925A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN IMMUNOTHERAPY OF SEVERAL TUMOR SPECIES
MX2019006045A (en) Psma targeting trispecific proteins and methods of use.
EP3708185A3 (en) Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll)
CR20160018A (en) NEW IMMUNOTHERAPY AGAINST VARIOUS TUMORS LIKE CANCER OF LUNG, INCLUDING THE CARCINOMA OF PULMON AMICROCÍTICO (NSCLC)
PH12021551208A1 (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MX390894B (en) ANTI-CANCER FUSION POLYPEPTIDE.
EA201792409A2 (en) NEW METHODS OF IMMUNOTHERAPY OF MULTIPLE TUMOR TYPES, INCLUDING CANCER OF THE GASTRIC AND INTESTINAL TRACT
WO2021181233A3 (en) Cd80-fc fusion protein and uses thereof
EA201991444A1 (en) NEW PEPTIDES AND PEPTID COMBINATIONS FOR APPLICATION IN THE IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER
BR112015004349A2 (en) ube2t peptides and vaccines containing the same
MX2019014546A (en) A peptide with anti-cancer activity and with selectivity to breast cancer cells.
PH12016502008A1 (en) Novel immunotherapy against several tumors of the blood, such as acute myeloid lukemia (aml)
MY201635A (en) Antibodies of increased affinity for the epidermal growth factor receptor and its derived fragments
EA201992860A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER (NSCLC), SMALL-CELL LUNG CANCER (MRL) AND OTHER
EA201990588A1 (en) NEW PEPTIDES AND FRAMES FOR APPLICATION IN THE IMMUNOTHERAPY OF Squamous cell carcinoma of the head and neck and other types of cancer
MY194241A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including NSCLC
MY193910A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194653A (en) Novel immunotherapy against several tumors, such as lung cancer, including nsclc
MY194244A (en) Novel Immunotherapy Against Several Tumors, Such as Lung Cancer, Including Nsclc
EA202090822A2 (en) A NEW METHOD FOR IMMUNOTHERAPY OF SEVERAL TUMORS OF TUMORS SUCH AS LUNG CANCER, INCLUDING NSCLC